Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages

  Nanda, Akash ^a   Chen, Ming Hui ^b   Moran, Brian J ^c   Braccioforte, Michelle H ^c   D'Amico, Anthony V ^d  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Prostate Cancer Foundation of Chicago   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE HEART FAILURES; CORONARY ARTERY DISEASE; DECISION MAKING PROCESS; HYPERCHOLESTEROLEMIA; METHODS AND MATERIALS; MULTIVARIABLE ANALYSIS; MYOCARDIAL INFARCTION; PROSTATE SPECIFIC ANTIGEN;

CARDIOLOGY; DISEASES;

EPIDEMIOLOGY;

PROSTATE SPECIFIC ANTIGEN;

AGE; AGED; ARTICLE; BRACHYTHERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART FAILURE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84875279846     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.11.039     Document Type: Article

References (20)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M.J. Hayat, N. Howlader, and M.E. Reichman Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program Oncologist 12 2007 20 37
3. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
4. G.L. Andriole, E.D. Crawford, and R.L. Grubb 3rd Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
5. A. Nanda, M.H. Chen, and M.H. Braccioforte Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction JAMA 302 2009 866 873
6. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics - 2010 update: A report from the American Heart Association Circulation 121 2010 e46 e215
7. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
8. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel Int J Radiat Oncol Biol Phys 37 1997 1035 1041
9. A. Agresti Categorical Data Analysis 2nd ed. 2002 John Wiley & Sons New York
10. M. Hollander, and D.A. Wolfe Nonparametric Statistical Methods 2nd ed. 1999 John Wiley & Sons New York
11. J.P. Klein, and M.L. Moeschberger Survival Analysis 2nd ed. 2003 Springer-Verlag New York
12. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Lippincott Philadelphia
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. L.A. Cupples, D.R. Gagnon, and R. Ramaswamy Age-adjusted survival curves with application in the Framingham Study Stat Med 14 1995 1731 1744
15. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
16. J.P. Shaffer Multiple hypothesis testing Ann Rev Psychol 46 1995 571 584
17. J.F. Piccirillo, R.M. Tierney, and I. Costas Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447
18. J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
19. R. Gutt, N. Tonlaar, and R. Kunnavakkam Statin use and risk of prostate cancer recurrence in men treated with radiation therapy J Clin Oncol 28 2010 2653 2659
20. M.A. Kollmeier, M.S. Katz, and K. Mak Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 79 2011 713 718